Matteo Bellone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matteo Bellone has a total of 664 co-authors. Here are the top co-authors by number of shared publications:
- Elena Jachetti
Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
31 shared publications - Matteo Grioni
IRCCS Ospedale San Raffaele 1 Cellular Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases Milan, Italy
29 shared publications - Laura Lucia Cogrossi
IRCCS Ospedale San Raffaele 1 Cellular Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases Milan, Italy
28 shared publications - Marco Lorenzoni
IRCCS Ospedale San Raffaele 1 Cellular Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases Milan, Italy
27 shared publications - Paola Zordan
IRCCS Ospedale San Raffaele 1 Cellular Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases Milan, Italy
27 shared publications Matteo Grioni
Cellular immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele
26 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Springer Nature in Cell Communication and Signaling
The gut microbiome in multiple myeloma: from disease evolution to therapeutic modulation
- 22 September 2026
- Published by Springer Nature in Cell Communication and Signaling
Open AccessThe gut microbiome in multiple myeloma: from disease evolution to therapeutic modulation
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Efficacy of CA-3 treatment in mouse models of PC
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Efficacy of CA-3 treatment in mouse models of PC
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Polarized light analysis of ECM linearization in human prostate cancer specimen
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Polarized light analysis of ECM linearization in human prostate cancer specimen
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Identified proteins in the mouse ECM
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Identified proteins in the mouse ECM
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Inhibition of α2 reduces invasiveness of PNE and PAC cells
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Inhibition of α2 reduces invasiveness of PNE and PAC cells
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Adverse events in CA-3 vs vehicle treated mice
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Adverse events in CA-3 vs vehicle treated mice
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Gene signatures used for transcriptomic analysis
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Gene signatures used for transcriptomic analysis
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Divergence of the proteomes of ECMs obtained from TRAMP and WT prostates
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Divergence of the proteomes of ECMs obtained from TRAMP and WT prostates
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Differentially expressed matrisome genes discriminate human NEPC and CRPC-Adeno
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
Differentially expressed matrisome genes discriminate human NEPC and CRPC-Adeno
- Open Access
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 11 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
CA-3 inhibits NEPC and not WT organoids
- 15 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 11 from Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression
CA-3 inhibits NEPC and not WT organoids